Table 1.
The association between KIF15 expression and clinical-pathological characteristics in breast cancers
| Clinical-pathological characteristics | Total case | Over-expression of KIF15 | P value |
|---|---|---|---|
| Age | 0.249 | ||
| <50 | 36 | 11 | |
| ≥50 | 54 | 23 | |
| Tumor Size (cm) | 0.895 | ||
| ≤2 | 59 | 22 | |
| >2 | 31 | 12 | |
| Lymph-node metastasis | 0.142 | ||
| Negative | 46 | 14 | |
| Positive | 44 | 20 | |
| TNM stage | |||
| I-II | 62 | 23 | 0.843 |
| III-IV | 28 | 11 | |
| ER status | 0.859 | ||
| Negative | 36 | 14 | |
| Positive | 54 | 20 | |
| PR status | 0.509 | ||
| Negative | 41 | 17 | |
| Positive | 49 | 17 | |
| Her-2 expression | 0.925 | ||
| Negative | 71 | 27 | |
| Positive | 19 | 7 | |
| Ki-67 status | 0.002** | ||
| ≤14% | 43 | 9 | |
| >14% | 47 | 25 | |
| WHO grade | <0.0001*** | ||
| I-II | 51 | 10 | |
| III | 39 | 24 |
**P<0.001, ***P<0.0001.